|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tao Z, Shi A, Lu C, Song T, Zhang Z and
Zhao J: Breast cancer: Epidemiology and etiology. Cell Biochem
Biophys. 72:333–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Fedewa SA, Goding Sauer A,
Kramer JL, Smith RA and Jemal A: Breast cancer statistics, 2015:
Convergence of incidence rates between black and white women. CA
Cancer J Clin. 66:31–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qian C, Guan M, Si C, Shen H, Jin T and
Zhang T: Identification of differentially expressed profiles of
lncRNAs and mRNAs in ER-negative and HER-2 positive breast cancer.
Arch Med Sci Civil Dis. 2:148–160. 2017.
|
|
5
|
Hortobagyi GN, Stemmer SM, Burris HA, Yap
YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F,
Winer EP, et al: Ribociclib as first-line therapy for HR-positive,
advanced breast cancer. N Engl J Med. 375:1738–1748. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
You H, Lin H and Zhang Z: CKS2 in human
cancers: Clinical roles and current perspectives. Mol Clin Oncol.
3:459–463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liberal V, Martinsson-Ahlzén HS, Liberal
J, Spruck CH, Widschwendter M, McGowan CH and Reed SI:
Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression
overrides the DNA damage response barrier triggered by activated
oncoproteins. Proc Natl Acad Sci USA. 109:2754–2759. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Litchfield DW: Protein kinase CK2:
Structure, regulation and role in cellular decisions of life and
death. Biochem J. 369:1–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinsson-Ahlzén HS, Liberal V,
Grünenfelder B, Chaves SR, Spruck CH and Reed SI: Cyclin-dependent
kinase-associated proteins Cks1 and Cks2 are essential during early
embryogenesis and for cell cycle progression in somatic cells. Mol
Cell Biol. 28:5698–5709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen R, Feng C and Xu Y: Cyclin-dependent
kinase-associated protein Cks2 is associated with bladder cancer
progression. J Int Med Res. 39:533–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin L, Fang Z, Lin H, You H, Wang J, Su Y,
Wang F and Zhang ZY: Depletion of Cks1 and Cks2 expression
compromises cell proliferation and enhance chemotherapy-induced
apoptosis in HepG2 cells. Oncol Rep. 35:26–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Xu L, Liu Y, Chen J, Jiang H, Yang
S and Tan H: Expression of cyclin kinase subunit 2 in human breast
cancer and its prognostic significance. Int J Clin Exp Pathol.
7:8593–8601. 2014.PubMed/NCBI
|
|
13
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature. 486:346–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sørlie T, Tibshirani R, Parker J, Hastie
T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et
al: Repeated observation of breast tumor subtypes in independent
gene expression data sets. Proc Natl Acad Sci USA. 100:8418–8423.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pontén F, Jirström K and Uhlen M: The
Human Protein Atlas-a tool for pathology. J Pathol. 216:387–393.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu XF, Zeng D, Liang WQ, Chen CF, Sun SM
and Lin HY: FoxM1 is a promising candidate target in the treatment
of breast cancer. Oncotarget. 9:842–852. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jézéquel P, Frénel JS, Campion L,
Guérin-Charbonnel C, Gouraud W, Ricolleau G and Campone M:
bc-GenExMiner 3.0: New mining module computes breast cancer gene
expression correlation analyses. Database (Oxford).
2013:bas0602013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Malumbres M and Barbacid M: Mammalian
cyclin-dependent kinases. Trends Biochem Sci. 30:630–641. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao H, Lu Z, Bauzon F, Fu H, Cui J,
Locker J and Zhu L: p27T187A knockin identifies Skp2/Cks1 pocket
inhibitors for advanced prostate cancer. Oncogene. 36:60–70. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Z, Zhou Y, Tu B, Bu Y, Liu A and Kong
J: Long noncoding RNA MALAT1 affects the efficacy of radiotherapy
for esophageal squamous cell carcinoma by regulating Cks1
expression. J Oral Pathol Med. 46:583–590. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu L, Fan S, Zhao J, Zhou P, Chu S, Luo J,
Wen Q, Chen L, Wen S, Wang L and Shi L: Increased expression of
Cks1 protein is associated with lymph node metastasis and poor
prognosis in nasopharyngeal carcinoma. Diagn Pathol. 12:22017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang D, Zhi T, Xu X, Bao Z, Fan L, Li Z,
Ji J and Liu N: MicroRNA-936 induces cell cycle arrest and inhibits
glioma cell proliferation by targeting CKS1. Am J Cancer Res.
7:2131–2143. 2017.PubMed/NCBI
|
|
26
|
Kang MA, Kim JT, Kim JH, Kim SY, Kim YH,
Yeom YI, Lee Y and Lee HG: Upregulation of the cycline kinase
subunit CKS2 increases cell proliferation rate in gastric cancer. J
Cancer Res Clin Oncol. 135:761–769. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ji X, Xue Y, Wu Y, Feng F and Gao X:
High-expressed CKS2 is associated with hepatocellular carcinoma
cell proliferation through down-regulating PTEN. Pathol Res Pract.
214:436–441. 2018. View Article : Google Scholar : PubMed/NCBI
|
